Education
About Us
Working with TipRanks
Follow Us
Immuneering (IMRX)
NASDAQ:IMRX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 316.95K | $ 2.08M | $ 2.31M |
| Gross Profit | $ 0.00 | $ -764.14K | $ 158.83K | $ 926.89K | $ 1.03M |
| Operating Income | $ -64.07B | $ -58.41M | $ -51.74M | $ -33.89M | $ -17.08M |
| EBITDA | $ -64.07B | $ -58.06M | $ -51.47M | $ -33.68M | $ -17.00M |
| Net Income | $ -61.04B | $ -53.47M | $ -49.28M | $ -33.54M | $ -17.04M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 36.14B | $ 85.67M | $ 105.52M | $ 149.20M | $ 37.09M |
| Total Assets | $ 52.71B | $ 102.58M | $ 122.37M | $ 166.70M | $ 38.42M |
| Total Debt | $ 4.16B | $ 4.46M | $ 4.84M | $ 5.36M | $ 621.09K |
| Net Debt | $ -31.98B | $ -54.94M | $ -67.80M | $ -69.52M | $ -36.47M |
| Total Liabilities | $ 11.33B | $ 12.01M | $ 12.52M | $ 10.72M | $ 60.90M |
| Stockholders' Equity | $ 41.39B | $ 90.58M | $ 109.85M | $ 155.98M | $ -22.48M |
| Cash Flow | |||||
| Free Cash Flow | $ -55.08M | $ -49.31M | $ -44.84M | $ -30.91M | $ -14.67M |
| Operating Cash Flow | $ -55.00M | $ -48.97M | $ -44.10M | $ -30.85M | $ -14.62M |
| Investing Cash Flow | $ 26.43M | $ 7.30M | $ 41.83M | $ -75.62M | $ -53.41K |
| Financing Cash Flow | $ 5.30M | $ 28.44M | $ 19.00K | $ 144.26M | $ 37.98M |